Clinical effectiveness and safety of preoperative oral carbohydrate loading in patients with diabetes: A systematic review

IF 4.3 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes & Metabolic Syndrome-Clinical Research & Reviews Pub Date : 2024-10-01 DOI:10.1016/j.dsx.2024.103140

Chunxiu Zhao , Jinghong Shi , Na Zhu , Pingliang Yang , Bingbing Xiang , Yunke Dai , Shun Wang

{"title":"Clinical effectiveness and safety of preoperative oral carbohydrate loading in patients with diabetes: A systematic review","authors":"Chunxiu Zhao , Jinghong Shi , Na Zhu , Pingliang Yang , Bingbing Xiang , Yunke Dai , Shun Wang","doi":"10.1016/j.dsx.2024.103140","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The effectiveness and safety of preoperative oral carbohydrate (POC) for people with diabetes remain controversial.</div></div><div><h3>Methods</h3><div>We systematically reviewed studies comparing POC to fasting or placebo in elective surgery for diabetic adults, focusing on gastric volume, postoperative complications, hospital stay, and glycemic control.</div></div><div><h3>Results</h3><div>Fourteen studies (n = 1870 patients) were included. POC did not significantly increase gastric volume or aspiration risk in well-controlled type 2 diabetes. Effects on perioperative glucose control varied. POC improved patient comfort and reduced preoperative hypoglycemia in gestational diabetes. Limited evidence suggested potential benefits in cardiac surgery patients.</div></div><div><h3>Conclusion</h3><div>POC is safe for well-controlled type 2 diabetics, enhancing comfort and reducing preoperative hypoglycemia without increasing aspiration risk. However, its effects on glucose control and postoperative outcomes vary. Personalized approaches are crucial, particularly for poorly controlled diabetes.</div></div>","PeriodicalId":48252,"journal":{"name":"Diabetes & Metabolic Syndrome-Clinical Research & Reviews","volume":"18 10","pages":"Article 103140"},"PeriodicalIF":4.3000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes & Metabolic Syndrome-Clinical Research & Reviews","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871402124002017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Background

The effectiveness and safety of preoperative oral carbohydrate (POC) for people with diabetes remain controversial.

Methods

We systematically reviewed studies comparing POC to fasting or placebo in elective surgery for diabetic adults, focusing on gastric volume, postoperative complications, hospital stay, and glycemic control.

Results

Fourteen studies (n = 1870 patients) were included. POC did not significantly increase gastric volume or aspiration risk in well-controlled type 2 diabetes. Effects on perioperative glucose control varied. POC improved patient comfort and reduced preoperative hypoglycemia in gestational diabetes. Limited evidence suggested potential benefits in cardiac surgery patients.

Conclusion

POC is safe for well-controlled type 2 diabetics, enhancing comfort and reducing preoperative hypoglycemia without increasing aspiration risk. However, its effects on glucose control and postoperative outcomes vary. Personalized approaches are crucial, particularly for poorly controlled diabetes.

查看原文本刊更多论文

糖尿病患者术前口服碳水化合物负荷的临床有效性和安全性：系统综述

背景糖尿病患者术前口服碳水化合物（POC）的有效性和安全性仍存在争议。方法我们系统回顾了在糖尿病成人择期手术中比较 POC 与禁食或安慰剂的研究，重点关注胃容量、术后并发症、住院时间和血糖控制。在控制良好的 2 型糖尿病患者中，POC 不会明显增加胃容量或吸入风险。对围术期血糖控制的影响各不相同。POC 提高了患者的舒适度，减少了妊娠糖尿病患者术前低血糖的发生。有限的证据表明，POC 对心脏手术患者有潜在的益处。结论 POC 对控制良好的 2 型糖尿病患者是安全的，可提高舒适度并减少术前低血糖，同时不会增加吸入风险。然而，它对血糖控制和术后效果的影响各不相同。个性化方法至关重要，尤其是对于控制不佳的糖尿病患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes & Metabolic Syndrome-Clinical Research & Reviews ENDOCRINOLOGY & METABOLISM-

CiteScore

22.90

自引率

2.00%

发文量

248

审稿时长

51 days

期刊介绍： Diabetes and Metabolic Syndrome: Clinical Research and Reviews is the official journal of DiabetesIndia. It aims to provide a global platform for healthcare professionals, diabetes educators, and other stakeholders to submit their research on diabetes care. Types of Publications: Diabetes and Metabolic Syndrome: Clinical Research and Reviews publishes peer-reviewed original articles, reviews, short communications, case reports, letters to the Editor, and expert comments. Reviews and mini-reviews are particularly welcomed for areas within endocrinology undergoing rapid changes.